Retroviral vector‐producing mesenchymal stem cells for targeted suicide cancer gene therapy
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Background: Mesenchymal stem cells (MSCs) are a promising vehicle for targeted cancer gene therapy because of their potential of tumor tropism. For efficient therapeutic application, we developed retroviral vector‐producing MSCs that enhance tumor transduction via progeny vector production. Methods: Rat bone marrow‐derived MSCs were nucleofected with the proviral plasmids (vesicular stomatitis virus‐G protein‐pseudotyped retroviral vector components) (VP‐MSCs) or pLTR plasmid alone (non‐VP‐MSCs). The luciferase‐based in vivo imaging system was used to assess gene expression periodically. To evaluate the anticancer effects, we administered MSCs expressing herpes simplex virus‐thymidine kinase (HSV‐tk) into the left ventricular cavity of nude mice engrafted with 9L glioma cells subcutaneously. Results: In vivo imaging revealed that administration of luciferase‐expressing non‐VP‐MSCs enhanced the bioluminescence signal at the inoculation sites of 9L cells, whereas no accumulation was observed in mice at the site of the control Rat‐1 fibroblasts. Compared to non‐VP‐MSCs, the administration of VP‐MSCs resulted in significant augmentation of the signal with an increase in transgene copy number. Immunohistochemical analysis showed marked luciferase expression at the tumor periphery in mice injected with VP‐MSCs, whereas little expression was detected in those injected with non‐VP‐MSCs. Under the continuous infusion of ganciclovir, systemic administration of VP‐MSCs expressing HSV‐tk suppressed tumor growth more effectively than non‐VP‐MSC administration, whereas no anticancer effect was observed without ganciclovir treatment. Furthermore, VP‐MSC administration caused no transgene transduction in the normal tissues and organs. Conclusions: VP‐MSCs accumulated at the site of tumors after intravascular injection in tumor‐bearing mice, followed by in situ gene transfer to tumors without transduction of normal organs. When applied to the HSV‐tk/ganciclovir suicide gene therapy, more efficient tumor growth suppression was observed using VP‐MSCs compared to non‐VP‐MSCs. This VP‐MSC‐based system has great potential for improved cancer gene therapy. Copyright © 2009 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Human mesenchymal stem cells modulate allogeneic immune cell responses
Aggarwal, S., & Pittenger, M. F. (2005) · Blood · doi:10.1182/blood-2004-04-1559 · Cited by 4,511
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206
Le Blanc, K., Rasmusson, I., Sundberg, B., Götherström, C., Hassan, M., Uzunel, M., & Ringdén, O. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16104-7 · Cited by 2,734
Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model
Nakamura, K., Ito, Y., Kawano, Y., Kurozumi, K., Kobune, M., Tsuda, H., Bizen, A., Honmou, O., Niitsu, Y., & Hamada, H. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302276 · Cited by 597 · cited 1×
“MSCs were prepared from the rat bone marrow as described previously [13].”
MethodMesenchymal Stem Cells in Cancer: Tumor-Associated Fibroblasts and Cell-Based Delivery Vehicles
Hall, B., Dembinski, J., Sasser, A., Studeny, M., Andreeff, M., & Marini, F. (2007) · International Journal of Hematology · doi:10.1532/ijh97.06230 · Cited by 171
Research works printed but not linked: 12
- 10.1038/nm1297-1354 · DOI · Paper page
- 10.1089/104303400750038499 · DOI · Paper page
- 10.1158/0008-5472.CAN-04-1874 · DOI · Paper page
- 10.1016/j.jaut.2007.12.008 · DOI
- 10.1038/sj.bmt.1704400 · DOI · Paper page
- 10.1016/S0092-8674(00)81683-9 · DOI · Paper page
- 10.1007/978-3-540-68976-8_12 · DOI · Paper page
- 10.1016/j.bbmt.2005.01.005 · DOI · Paper page
- Studeny M, 2002, Bone marrow‐derived mesenchymal stem cells as vehicles for interferon‐beta delivery into tumors, Cancer Res, 62, 3603
- 10.1002/jgm.490 · doi:10.1002/jgm.490
- 10.1634/stemcells.2005-0198 · DOI
- 10.1089/scd.2005.14.252 · DOI · Paper page
Cited by
Stem cells as vectors for antitumour therapy
Loebinger, M. R., & Janes, S. M. (2010) · Thorax · doi:10.1136/thx.2009.128025 · Cited by 109
Ramamonjisoa, N., & Ackerstaff, E. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00003 · Cited by 93
“The preferential accumulation of MSCs at sites of inflammation and tumors makes them an ideal vehicle for treatment delivery (155, 181, 182), and combined treatment/imaging MSC moieties are being developed for cell tracking and treatment monitoring (175, 177, 178, 183).”
BackgroundMesenchymal stromal cells for bone sarcoma treatment: Roadmap to clinical practice
Stamatopoulos, A., Stamatopoulos, T., Gamie, Z., Kenanidis, E., Ribeiro, R. D. C., Rankin, K. S., Gerrand, C., Dalgarno, K., & Tsiridis, E. (2019) · Journal of Bone Oncology · doi:10.1016/j.jbo.2019.100231 · Cited by 37
“combined MSCs that produced herpes simplex virus-thymidine kinase retroviral vectors with the prodrug ganciclovir leading to glioma cell death both in vitro and in vivo [131].”
BackgroundXU, G., GUO, Y., SENG, Z., CUI, G., & QU, J. (2015) · Oncology Reports · doi:10.3892/or.2015.4174 · Cited by 35
“BMSCs expressing herpes simplex virus-thymidine kinase suppress glioma tumor growth in a mouse model (28).”
BackgroundCell Therapy as Target Therapy against Colon Cancer Stem Cells
Garza Treviño, E. N., Quiroz Reyes, A. G., Rojas Murillo, J. A., de la Garza Kalife, D. A., Delgado Gonzalez, P., Islas, J. F., Estrada Rodriguez, A. E., & Gonzalez Villarreal, C. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098163 · Cited by 24
Metadata
- Authors
- Uchibori, R., Okada, T., Ito, T., Urabe, M., Mizukami, H., Kume, A., & Ozawa, K.
- Venue
- The Journal of Gene Medicine
- Publisher
- Wiley
- Published
- 2009-03-09
- Volume
- 11
- Issue
- 5
- Pages
- 373-381
- ISSN
- 1099-498X (ISSN-L)
- 1521-2254
- OpenAlex
- W2019713216
- Cited by
- 128
- References
- 5
- FWCI
- 6.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Retroviral vector‐producing mesenchymal stem cells for targeted suicide cancer gene therapy. https://app.cochat.ai/papers/10.1002/jgm.1313
- The paper
- Uchibori, R., Okada, T., Ito, T., Urabe, M., Mizukami, H., Kume, A., & Ozawa, K. (2009). Retroviral vector‐producing mesenchymal stem cells for targeted suicide cancer gene therapy. The Journal of Gene Medicine. https://doi.org/10.1002/jgm.1313
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.